turing-pharmaceuticals
U.S. prosecutors consider more charges against ex-CEO Shkreli
May 3, 2016 by admin · Leave a Comment
NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor
Read more from the original source:
U.S. prosecutors consider more charges against ex-CEO Shkreli
turing-pharmaceuticals
Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’
February 4, 2016 by publisher · Leave a Comment
By Sarah N. Lynch and David Ingram WASHINGTON/NEW YORK (Reuters) – Former drug executive Martin Shkreli smirked and brushed off questions about drug prices then tweeted that lawmakers were imbeciles on Thursday, when he appeared at a U.S. congressional hearing against his will. Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential front-runner Hillary Clinton after his company, Turing Pharmaceuticals, raised the price of the drug Daraprim by more than 5,000 percent to $750 a pill. At a hearing of the U.S. House…
Read the rest here:
Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’
turing-pharmaceuticals
Turing Pharma seeks CEO to replace Shkreli, plans job cuts
December 23, 2015 by publisher · Leave a Comment
Shkreli, 32, resigned as CEO on Friday, a day after his arrest on charges that he had engaged in a Ponzi-like scheme. On Monday, KaloBios Pharmaceuticals said Shkreli was “terminated” as CEO and had resigned from the board. Turing did not specify the number of job cuts in a statement.
Go here to read the rest:
Turing Pharma seeks CEO to replace Shkreli, plans job cuts